Oxidatively modified RNA in mild cognitive impairment

Neurobiology of Disease

Volumn 29, Issue 2, 2008, Pages 169-175

  Lovell, Mark A ^a,b   Markesbery, William R ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Alzheimer's disease; Lipid peroxidation; Mild cognitive impairment; Oxidative stress; RNA

Indexed keywords

1 N2 PROPANODEOXYGUANOSINE; 8 HYDROXYGUANINE; ANTIBODY; DEOXYRIBONUCLEASE I; GUANOSINE DERIVATIVE; RIBONUCLEASE; RNA; TAU PROTEIN; UNCLASSIFIED DRUG;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN LEVEL; BRAIN NERVE CELL; CLINICAL ARTICLE; COGNITIVE DEFECT; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MOLECULAR RECOGNITION; NEUROFIBRILLARY TANGLE; OXIDATION; PRIORITY JOURNAL; PROTEIN CONFORMATION; SUBICULUM; TISSUE SECTION;

ADENOSINE TRIPHOSPHATASES; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; BRAIN; CATION TRANSPORT PROTEINS; COGNITION DISORDERS; DEOXYGUANOSINE; FEMALE; GUANINE; HUMANS; MALE; MICROSCOPY, CONFOCAL; OXIDATION-REDUCTION; OXIDATIVE STRESS; POSTMORTEM CHANGES; RNA; STATISTICS, NONPARAMETRIC;

EID: 38149087424     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2007.07.030     Document Type: Article

References (44)

1. Banerjee A., Roach M.C., Trcka P., and Luduena R.F. Increased microtubule assembly in bovine brain tubulin lacking the type III isotype of beta-tubulin. J. Biol. Chem. 265 (1990) 1794-1799
2. Beelman C.A., and Parker R. Degradation of mRNA in eukaryotes. Cell 81 (1995) 179-183
3. Bennett D.A., Wilson R.S., Schneider J.A., Evans D.A., Beckett L.A., Aggarwal N.T., Barnes L.L., Fox J.H., and Bach J. Natural history of mild cognitive impairment in older persons. Neurology 59 (2002) 198-205
4. Calingasan N.Y., Uchida K., and Gibson G.E. Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer's disease. J. Neurochem. 72 (1999) 751-756
5. Chung F.L., Young R., and Hecht S.S. Formation of cyclic 1,N2-propanodeoxyguanosine adducts in DNA upon reaction with acrolein or crotonaldehyde. Cancer Res. 44 (1984) 990-995
6. DeCarli C. Mild cognitive impairment: prevalence, prognosis, aetiology, and treatment. Lancet Neurol. 2 (2003) 15-21
7. Ding Q., Markesbery W.R., Chen Q., Li F., and Keller J.N. Ribosome dysfunction is an early event in Alzheimer's disease. J. Neurosci. 25 (2005) 9171-9175
8. Ding Q., Markesbery W.R., Cecarini V., and Keller J.N. Decreased RNA, and increased RNA oxidation, in ribosomes from early Alzheimer's disease. Neurochem. Res. 31 (2006) 705-710
9. Honda K., Smith M.A., Zhu X., Baus D., Merrick W.C., Tartakoff A.M., Hattier T., Harris P.L., Siedlak S.L., Fujioka H., Liu Q., Moreira P.I., Miller F.P., Nunomura A., Shimohama S., and Perry G. Ribosomal RNA in Alzheimer disease is oxidized by bound redox-active iron. J. Biol. Chem. 280 (2005) 20978-20986
10. Jezowska-Bojczuk M., Szczepanik W., Lesniak W., Ciesiolka J., Wrzesinski J., and Bal W. DNA and RNA damage by Cu(II)-amikacin complex. Eur. J. Biochem. 269 (2002) 5547-5556
11. Jicha G.A., Bowser R., Kazam I.G., and Davies P. Alz-50 and MC1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau. J. Neurosci. Res. 48 (1997) 128-132
12. Keller J.N., Schmitt F.A., Scheff S.W., Ding Q., Chen Q., Butterfield D.A., and Markesbery W.R. Evidence of increased oxidative damage in subjects with mild cognitive impairment. Neurology 64 (2005) 1152-1156
13. Knopman D.S., Parisi J.E., Salviati A., Floriach-Robert M., Boeve B.F., Ivnik R.J., Smith G.E., Dickson D.W., Johnson K.A., Petersen L.E., McDonald W.C., Braak H., and Petersen R.C. Neuropathology of cognitively normal elderly. J. Neuropathol. Exp. Neurol. 62 (2003) 1087-1095
14. Liu X., Lovell M.A., and Lynn B.C. Development of a method for quantification of acrolein-deoxyguanosine adducts in DNA using isotope dilution-capillary LC/MS/MS and its application to human brain tissue. Anal. Chem. 77 (2005) 5982-5989
15. Lovell M.A., Xie C., and Markesbery W.R. Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures. Neurobiol. Aging 22 (2001) 187-194
16. Markesbery W.R., and Lovell M.A. Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease. Neurobiol. Aging 19 (1998) 33-36
17. Markesbery W.R., Kryscio R.J., Lovell M.A., and Morrow J.D. Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment. Ann. Neurol. 58 (2005) 730-735
18. Markesbery W.R., Schmitt F.A., Kryscio R.J., Davis D.G., Smith C.D., and Wekstein D.R. Neuropathologic substrate of mild cognitive impairment. Arch. Neurol. 63 (2006) 38-46
19. Martinet W., de Meyer G.R., Herman A.G., and Kockx M.M. Reactive oxygen species induce RNA damage in human atherosclerosis. Eur. J. Clin. Investig. 34 (2004) 323-327
20. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34 (1984) 939-944
21. Mirra S.S., Heyman A., McKeel D., Sumi S.M., Crain B.J., Brownlee L.M., Vogel F.S., Hughes J.P., van Belle G., and Berg L. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41 (1991) 479-486
22. Mitchell P., and Tollervey D. mRNA turnover. Curr. Opin. Cell Biol. 13 (2001) 320-325
23. Montine K.S., Olson S.J., Amarnath V., Whetsell Jr. W.O., Graham D.G., and Montine T.J. Immunohistochemical detection of 4-hydroxy-2-nonenal adducts in Alzheimer's disease is associated with inheritance of APOE4. Am. J. Pathol. 150 (1997) 437-443
24. Morris J.C., Heyman A., Mohs R.C., Hughes J.P., van Belle G., Fillenbaum G., Mellits E.D., and Clark C. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 39 (1989) 1159-1165
25. National Institute on Aging and Reagan Institute. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. Neurobiol. Aging 18 S4 (1997) S1-S2
26. Nunomura A., Perry G., Hirai K., Aliev G., Takeda A., Chiba S., and Smith M.A. Neuronal RNA oxidation in Alzheimer's disease and Down's syndrome. Ann. N.Y. Acad. Sci. 893 (1999) 362-364
27. Nunomura A., Perry G., Aliev G., Hirai K., Takeda A., Balraj E.K., Jones P.K., Ghanbari H., Wataya T., Shimohama S., Chiba S., Atwood C.S., Petersen R.B., and Smith M.A. Oxidative damage is the earliest event in Alzheimer disease. J. Neuropathol. Exp. Neurol. 60 (2001) 759-767
28. Nunomura A., Chiba S., Kosaka K., Takeda A., Castellani R.J., Smith M.A., and Perry G. Neuronal RNA oxidation is a prominent feature of dementia with Lewy bodies. Neuroreport 13 (2002) 2035-2039
29. Nunomura A., Chiba S., Lippa C.F., Cras P., Kalaria R.N., Takeda A., Honda K., Smith M.A., and Perry G. Neuronal RNA oxidation is a prominent feature of familial Alzheimer's disease. Neurobiol. Dis. 17 (2004) 108-113
30. Nunomura A., Honda K., Takeda A., Hirai K., Zhu X., Smith M.A., and Perry G. Oxidative damage to RNA in neurodegenerative diseases. J. Biomed. Biotechnol. 2006 (2006) 82323
31. Petersen R.C., Smith G.E., Waring S.C., Ivnik R.J., Tangalos E.G., and Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch. Neurol. 56 (1999) 303-308
32. Picklo M.J., Montine T.J., Amarnath V., and Neely M.D. Carbonyl toxicology and Alzheimer's disease. Toxicol. Appl. Pharmacol. 184 (2002) 187-197
33. Rinke J., and Brimacombe R. 30S ribosomal proteins cross-linked to 16S RNA by periodate oxidation followed by borohydride reduction. Mol. Biol. Rep. 4 (1978) 153-156
34. Shan X., and Lin C.L. Quantification of oxidized RNAs in Alzheimer's disease. Neurobiol. Aging 27 (2006) 657-662
35. Shan X., Tashiro H., and Lin C.L. The identification and characterization of oxidized RNAs in Alzheimer's disease. J. Neurosci. 23 (2003) 4913-4921
36. Singh S., Dwarakanath B.S., and Mathew T.L. DNA ligand Hoechst-33342 enhances UV induced cytotoxicity in human glioma cell lines. J. Photochem. Photobiol., B Biol. 77 (2004) 45-54
37. Sultana R., Perluigi M., and Butterfield D.A. Protein oxidation and lipid peroxidation in brain of subjects with Alzheimer's disease: insights into mechanism of neurodegeneration from redox proteomics. Antioxid. Redox Signal. 8 (2006) 2021-2037
38. Tucker M., and Parker R. Mechanisms and control of mRNA decapping in Saccharomyces cerevisiae. Annu. Rev. Biochem. 69 (2000) 571-595
39. van Hoof A., and Parker R. The exosome: a proteasome for RNA?. Cell 99 (1999) 347-350
40. van Hoof A., and Parker R. Messenger RNA degradation: beginning at the end. Curr. Biol. 12 (2002) R285-R287
41. Wang J., Markesbery W.R., and Lovell M.A. Increased oxidative damage in nuclear and mitochondrial DNA in mild cognitive impairment. J. Neurochem. 96 (2006) 825-832
42. Weaver C.L., Espinoza M., Kress Y., and Davies P. Conformational change as one of the earliest alterations of tau in Alzheimer's disease. Neurobiol. Aging 21 (2000) 719-727
43. Williams T.I., Lynn B.C., Markesbery W.R., and Lovell M.A. Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in Mild Cognitive Impairment and early Alzheimer's disease. Neurobiol. Aging 27 (2006) 1094-1099
44. Zhang J., Perry G., Smith M.A., Robertson D., Olson S.J., Graham D.G., and Montine T.J. Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons. Am. J. Pathol. 154 (1999) 1423-1429